Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Squamous cell carcinoma in situ lining the uterine cavity.

Anthuenis J, Baekelandt J, Bourgain C, De Rop C.

Eur J Gynaecol Oncol. 2016;37(1):135-8. Review.

PMID:
27048127
2.

Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.

Melchior L, Grauslund M, Bellosillo B, Montagut C, Torres E, Moragón E, Micalessi I, Frans J, Noten V, Bourgain C, Vriesema R, van der Geize R, Cokelaere K, Vercooren N, Crul K, Rüdiger T, Buchmüller D, Reijans M, Jans C.

Exp Mol Pathol. 2015 Dec;99(3):485-91. doi: 10.1016/j.yexmp.2015.09.004. Epub 2015 Sep 25.

PMID:
26407762
3.

[Genomics from bench to bedside: a change in perspective].

Bourgain C.

Med Sci (Paris). 2014 Nov;30 Spec No 2:14-7. doi: 10.1051/medsci/201430s203. Epub 2014 Nov 17. French.

4.

Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.

Derksen L, Tournaye H, Stoop D, Van Vaerenbergh I, Bourgain C, Polyzos NP, Haentjens P, Blockeel C.

Reprod Biomed Online. 2014 Mar;28(3):359-68. doi: 10.1016/j.rbmo.2013.10.019. Epub 2013 Oct 31.

PMID:
24456700
5.

A randomized trial comparing the endometrial effects of daily subcutaneous administration of 25 mg and 50 mg progesterone in aqueous preparation.

de Ziegler D, Sator M, Binelli D, Leuratti C, Cometti B, Bourgain C, Fu YS, Garhöfer G.

Fertil Steril. 2013 Sep;100(3):860-6. doi: 10.1016/j.fertnstert.2013.05.029. Epub 2013 Jun 24.

PMID:
23806850
6.

Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.

Fatemi HM, Polyzos NP, van Vaerenbergh I, Bourgain C, Blockeel C, Alsbjerg B, Papanikolaou EG, Humaidan P.

Fertil Steril. 2013 Sep;100(3):742-7. doi: 10.1016/j.fertnstert.2013.05.028. Epub 2013 Jun 24.

PMID:
23806846
7.

Quantitative damage-benefit evaluation of drug effects: major discrepancies between the general population, users and experts.

Reynaud M, Luquiens A, Aubin HJ, Talon C, Bourgain C.

J Psychopharmacol. 2013 Jul;27(7):590-9. doi: 10.1177/0269881113487809. Epub 2013 May 15.

PMID:
23676197
8.

Ovarian tissue cryopreservation by vitrification in olive baboons (papio anubis): a pilot study.

Nyachieo A, Spiessens C, Chai DC, Kiulia NM, Willemen D, Mwenda JM, Bourgain C, D'Hooghe TM.

Gynecol Obstet Invest. 2013;75(3):157-62. doi: 10.1159/000346084. Epub 2013 Feb 6.

PMID:
23391858
9.

Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.

Humaidan P, Van Vaerenbergh I, Bourgain C, Alsbjerg B, Blockeel C, Schuit F, Van Lommel L, Devroey P, Fatemi H.

Hum Reprod. 2012 Nov;27(11):3259-72. doi: 10.1093/humrep/des279. Epub 2012 Aug 28.

PMID:
22930004
10.

Genetic and environmental factors influencing the Placental Growth Factor (PGF) variation in two populations.

Sorice R, Ruggiero D, Nutile T, Aversano M, Husemoen L, Linneberg A, Bourgain C, Leutenegger AL, Ciullo M.

PLoS One. 2012;7(8):e42537. doi: 10.1371/journal.pone.0042537. Epub 2012 Aug 20.

11.

Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.

Hofland M, Cosyns S, De Sutter P, Bourgain C, Velkeniers B.

Gynecol Endocrinol. 2013 Mar;29(3):213-5. doi: 10.3109/09513590.2012.705375. Epub 2012 Jul 26.

PMID:
22835278
12.
13.

Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial.

García-Velasco JA, Kupesic S, Pellicer A, Bourgain C, Simón C, Mrazek M, Devroey P, Arce JC.

Reprod Biomed Online. 2012 Feb;24(2):153-62. doi: 10.1016/j.rbmo.2011.10.016. Epub 2011 Nov 4.

PMID:
22197127
14.

The reliability of the histological diagnosis of endometritis in asymptomatic IVF cases: a multicenter observer study.

Kasius JC, Broekmans FJ, Sie-Go DM, Bourgain C, Eijkemans MJ, Fauser BC, Devroey P, Fatemi HM.

Hum Reprod. 2012 Jan;27(1):153-8. doi: 10.1093/humrep/der341. Epub 2011 Oct 24.

PMID:
22025228
15.

The impact of chronic endometritis on reproductive outcome.

Kasius JC, Fatemi HM, Bourgain C, Sie-Go DM, Eijkemans RJ, Fauser BC, Devroey P, Broekmans FJ.

Fertil Steril. 2011 Dec;96(6):1451-6. doi: 10.1016/j.fertnstert.2011.09.039. Epub 2011 Oct 22.

PMID:
22019126
16.

A damage/benefit evaluation of addictive product use.

Bourgain C, Falissard B, Blecha L, Benyamina A, Karila L, Reynaud M.

Addiction. 2012 Feb;107(2):441-50. doi: 10.1111/j.1360-0443.2011.03675.x.

PMID:
21954999
17.

Invasive recurrence of an intestinal-type mucinous epithelial neoplasm of low malignant potential: case report and review of the literature.

Cosyns S, Leyder M, Bourgain C, De Sutter P.

Case Rep Oncol. 2011 May;4(2):426-32. doi: 10.1159/000331416. Epub 2011 Aug 31.

18.

Role of intra-operative touch imprint cytology in the treatment of breast cancer.

Van Eetvelde E, Vanhoeij M, Verfaillie G, Bourgain C, Lamote J.

Acta Chir Belg. 2011 May-Jun;111(3):130-5.

PMID:
21780518
19.

Premature progesterone rise and gene expression.

Van Vaerenbergh I, Fatemi HM, Bourgain C.

Hum Reprod. 2011 Oct;26(10):2913; author reply 2194. doi: 10.1093/humrep/der235. Epub 2011 Jul 18. No abstract available.

PMID:
21771768
20.

Association between a polymorphism in the promoter of a glutamate receptor subunit gene (GRIN2A) and alcoholism.

Domart MC, Benyamina A, Lemoine A, Bourgain C, Blecha L, Debuire B, Reynaud M, Saffroy R.

Addict Biol. 2012 Jul;17(4):783-5. doi: 10.1111/j.1369-1600.2011.00321.x. Epub 2011 Apr 20.

PMID:
21507155

Supplemental Content

Loading ...
Support Center